Cargando…

Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study

BACKGROUND: Pharmaceutical care is the pharmacist’s contribution to the care of individuals to optimize medicines use and improve health outcomes. The primary tool of pharmaceutical care is medication review. Defining and classifying Drug-Related Problems (DRPs) is an essential pillar of the medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Szilvay, András, Somogyi, Orsolya, Meskó, Attiláné, Zelkó, Romána, Hankó, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499984/
https://www.ncbi.nlm.nih.gov/pubmed/31053135
http://dx.doi.org/10.1186/s12913-019-4114-1
_version_ 1783415864719048704
author Szilvay, András
Somogyi, Orsolya
Meskó, Attiláné
Zelkó, Romána
Hankó, Balázs
author_facet Szilvay, András
Somogyi, Orsolya
Meskó, Attiláné
Zelkó, Romána
Hankó, Balázs
author_sort Szilvay, András
collection PubMed
description BACKGROUND: Pharmaceutical care is the pharmacist’s contribution to the care of individuals to optimize medicines use and improve health outcomes. The primary tool of pharmaceutical care is medication review. Defining and classifying Drug-Related Problems (DRPs) is an essential pillar of the medication review. Our objectives were to perform a pilot of medication review in Hungarian community pharmacies, a DRP classification was applied for the first time. Also, our goal was the qualitative and quantitative description of the discovered DRPs, and of the interventions for their solution in order to prove the safety relevance of the service and to map out the competence limits of GPs and community pharmacists to drug therapy. METHODS: The project took place in Hungarian community pharmacies. The study was performed with patients taking vitamin K antagonist (VKA) and/or ACE inhibitor and NSAID simultaneously (ACEI-NSAID). 61 pharmacists and 606 patients participated in the project. Pharmacists reviewed the medication for 3 months and the classification of DRPs was performed (category of DRP1 – DRP6). Patient data were statistically analyzed. RESULTS: Patients consumed on average 7.9 ± 3.1 medications and other products. 571 DRPs were detected in 540 patients, averaging 1.06 DRPs per patient (SD = 1.07). The highest frequency category was DRP5 (non-quantitative safety problem; 51.0%). The most common root cause was an interaction (42.0%) and non-adherence (19.4%.). The most commonly used intervention was education (25.4%) and medication replacement by the pharmacist (20.1%). The changing of the frequency and dosage in any direction were negligible. CONCLUSIONS: Patients are struggling with many DRPs that can be assessed and categorized by this system and which remain unrecognizable without pharmacists. Further projects need to be developed to assist in the development of physician-pharmacist cooperation and the widespread dissemination of pharmaceutical care.
format Online
Article
Text
id pubmed-6499984
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64999842019-05-09 Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study Szilvay, András Somogyi, Orsolya Meskó, Attiláné Zelkó, Romána Hankó, Balázs BMC Health Serv Res Research Article BACKGROUND: Pharmaceutical care is the pharmacist’s contribution to the care of individuals to optimize medicines use and improve health outcomes. The primary tool of pharmaceutical care is medication review. Defining and classifying Drug-Related Problems (DRPs) is an essential pillar of the medication review. Our objectives were to perform a pilot of medication review in Hungarian community pharmacies, a DRP classification was applied for the first time. Also, our goal was the qualitative and quantitative description of the discovered DRPs, and of the interventions for their solution in order to prove the safety relevance of the service and to map out the competence limits of GPs and community pharmacists to drug therapy. METHODS: The project took place in Hungarian community pharmacies. The study was performed with patients taking vitamin K antagonist (VKA) and/or ACE inhibitor and NSAID simultaneously (ACEI-NSAID). 61 pharmacists and 606 patients participated in the project. Pharmacists reviewed the medication for 3 months and the classification of DRPs was performed (category of DRP1 – DRP6). Patient data were statistically analyzed. RESULTS: Patients consumed on average 7.9 ± 3.1 medications and other products. 571 DRPs were detected in 540 patients, averaging 1.06 DRPs per patient (SD = 1.07). The highest frequency category was DRP5 (non-quantitative safety problem; 51.0%). The most common root cause was an interaction (42.0%) and non-adherence (19.4%.). The most commonly used intervention was education (25.4%) and medication replacement by the pharmacist (20.1%). The changing of the frequency and dosage in any direction were negligible. CONCLUSIONS: Patients are struggling with many DRPs that can be assessed and categorized by this system and which remain unrecognizable without pharmacists. Further projects need to be developed to assist in the development of physician-pharmacist cooperation and the widespread dissemination of pharmaceutical care. BioMed Central 2019-05-03 /pmc/articles/PMC6499984/ /pubmed/31053135 http://dx.doi.org/10.1186/s12913-019-4114-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Szilvay, András
Somogyi, Orsolya
Meskó, Attiláné
Zelkó, Romána
Hankó, Balázs
Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study
title Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study
title_full Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study
title_fullStr Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study
title_full_unstemmed Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study
title_short Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study
title_sort qualitative and quantitative research of medication review and drug-related problems in hungarian community pharmacies: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499984/
https://www.ncbi.nlm.nih.gov/pubmed/31053135
http://dx.doi.org/10.1186/s12913-019-4114-1
work_keys_str_mv AT szilvayandras qualitativeandquantitativeresearchofmedicationreviewanddrugrelatedproblemsinhungariancommunitypharmaciesapilotstudy
AT somogyiorsolya qualitativeandquantitativeresearchofmedicationreviewanddrugrelatedproblemsinhungariancommunitypharmaciesapilotstudy
AT meskoattilane qualitativeandquantitativeresearchofmedicationreviewanddrugrelatedproblemsinhungariancommunitypharmaciesapilotstudy
AT zelkoromana qualitativeandquantitativeresearchofmedicationreviewanddrugrelatedproblemsinhungariancommunitypharmaciesapilotstudy
AT hankobalazs qualitativeandquantitativeresearchofmedicationreviewanddrugrelatedproblemsinhungariancommunitypharmaciesapilotstudy